The cholinergic synapse and the site of memory
- PMID: 4330469
- DOI: 10.1126/science.174.4011.788
The cholinergic synapse and the site of memory
Abstract
A simple hypothesis can explain the results obtained to date if we disregard those results when we wait 30 minutes after original learning to inject. The hypothesis is that, as a result of learning, the postsynaptic endings at a specific set of synapses become more sensitive to transmitter. This sensitivity increases with time after initial learning and then declines. The rate at which such sensitivity increases depends on the amount of initial learning. If the curve of transmission plotted against time is displaced upward with anticholinesterases then the very low portions will show facilitation, and the high portions will cause block (Fig. 8). The middle portions will appear unaffected (unless special experimental tests are made). If the curve of transmission is displaced down with anticholinergics, then the middle portion will appear unaffected and only the very early or late components will show block. The results are evidence that synaptic conductance is altered as a result of learning. So far it seems (i) that cholinergic synapses are modified as a result of learning and that it probably is the postsynaptic membrane that becomes increasingly more sensitive to acetylcholine with time after learning, up to a certain point. (ii) After this point, sensitivity declines, leading to the phenomenon of forgetting. (iii) There is also good evidence that there is an initial phase of declining sensitivity to cholinesterase or increasing sensitivity to anticholinergics. This could reflect the existence of a parallel set of synapses with fast decay that serve as a shortterm store. (iv) Increasing the amount of learning leads to an increase in conductance in each of a set of synapses without an increase in their number. (v) Both original learning and extinction are subserved by cholinergic synapses.
Similar articles
-
Anticholinesterase amnesia as a function of massed or spaced retest.J Comp Physiol Psychol. 1972 Oct;81(1):64-8. doi: 10.1037/h0033318. J Comp Physiol Psychol. 1972. PMID: 4342286 No abstract available.
-
Amnesia induced by scopolamine and its temporal variations.Nature. 1967 Oct 7;216(5110):89-90. doi: 10.1038/216089b0. Nature. 1967. PMID: 4292965 No abstract available.
-
Memory access pathway: role of adrenergic versus cholinergic neurons.Pharmacol Biochem Behav. 1973 May-Jun;1(3):295-300. doi: 10.1016/0091-3057(73)90120-2. Pharmacol Biochem Behav. 1973. PMID: 4775859 No abstract available.
-
The search for the chemistry of memory: recent trends and the logic of investigation in the role of cholinergic and adrenergic transmitters.Prog Neurobiol. 1975;2:291-307. Prog Neurobiol. 1975. PMID: 169545 No abstract available.
-
Cholinergic synaptic transmission and its relationship to behavior.Psychol Bull. 1966 Jun;65(6):321-35. doi: 10.1037/h0023350. Psychol Bull. 1966. PMID: 5327686 Review. No abstract available.
Cited by
-
ASS234, As a New Multi-Target Directed Propargylamine for Alzheimer's Disease Therapy.Front Neurosci. 2016 Jun 28;10:294. doi: 10.3389/fnins.2016.00294. eCollection 2016. Front Neurosci. 2016. PMID: 27445665 Free PMC article.
-
Nucleus basalis lesions attenuate acquisition, but not retention, of Pavlovian heart rate conditioning and have no effect on eyeblink conditioning.Exp Brain Res. 1992;89(3):501-10. doi: 10.1007/BF00229874. Exp Brain Res. 1992. PMID: 1644115
-
A double-blind, placebo controlled trial of high-dose lecithin in Alzheimer's disease.J Neurol Neurosurg Psychiatry. 1985 Aug;48(8):736-42. doi: 10.1136/jnnp.48.8.736. J Neurol Neurosurg Psychiatry. 1985. PMID: 3897460 Free PMC article. Clinical Trial.
-
Low-dose oral lorazepam administration in Alzheimer subjects and age-matched controls.Psychopharmacology (Berl). 1989;99(1):129-33. doi: 10.1007/BF00634466. Psychopharmacology (Berl). 1989. PMID: 2506598 Clinical Trial.
-
Is the distinction between Alzheimer's disease and vascular dementia possible and relevant?Dialogues Clin Neurosci. 2003 Mar;5(1):7-15. doi: 10.31887/DCNS.2003.5.1/rravonaspringer. Dialogues Clin Neurosci. 2003. PMID: 22033677 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
